Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 10, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | Innovative Payment Solutions, Inc. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 376,901,679 | |
Amendment Flag | false | |
Entity Central Index Key | 0001591913 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 000-55648 | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 33-1230229 | |
Entity Address, Address Line One | 56B 5th Avenue | |
Entity Address, Address Line Two | Lot 1 #AT | |
Entity Address, City or Town | Carmel By The Sea | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 93921 | |
City Area Code | (866) | |
Local Phone Number | 477-4729 | |
Entity Interactive Data Current | Yes |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Current Assets | ||
Cash | $ 155,868 | $ 374,765 |
Other current assets | 75,085 | 97,042 |
Total Current Assets | 230,953 | 471,807 |
Non-current assets | ||
Plant and equipment | 25,528 | 40,362 |
Intangible assets | 1,631,739 | 1,692,811 |
Security deposit | 47,592 | 47,592 |
Investment | 500,000 | 500,000 |
Total Non-Current Assets | 2,204,859 | 2,280,765 |
Total Assets | 2,435,812 | 2,752,572 |
Current Liabilities | ||
Accounts payable | 889,042 | 761,732 |
Federal relief loans – current portion | 3,217 | |
Notes payable | 988,368 | 964,268 |
Convertible debt, net of unamortized discount of $228,888 and $0, respectively | 2,632,451 | 2,266,602 |
Derivative liability | 1,609,892 | 2,550,642 |
Total Current Liabilities | 6,122,970 | 6,543,244 |
Non-Current Liabilities | ||
Federal relief loans | 159,952 | 163,978 |
Total Non-Current Liabilities | 159,952 | 163,978 |
Total Liabilities | 6,282,922 | 6,707,222 |
Equity (Deficit) | ||
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022. | ||
Common stock, $0.0001 par value; 750,000,000 shares authorized, 376,901,679 shares issued and outstanding as of March 31, 2023 and December 31, 2022. | 37,690 | 37,690 |
Additional paid-in-capital | 48,788,448 | 48,405,921 |
Accumulated deficit | (52,673,248) | (52,399,858) |
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders | (3,847,110) | (3,956,247) |
Non-controlling interest | 1,597 | |
Total Equity (Deficit) | (3,847,110) | (3,954,650) |
Total Liabilities and Equity (Deficit) | $ 2,435,812 | $ 2,752,572 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Convertible debt, net of unamortized discount (in Dollars) | $ 228,888 | $ 0 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 25,000,000 | 25,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 376,901,679 | 376,901,679 |
Common stock, shares outstanding | 376,901,679 | 376,901,679 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Net Revenue | $ 433 | |
Cost of Goods Sold | 2,085 | |
Gross loss | (1,652) | |
General and administrative | 965,207 | 869,387 |
Depreciation and amortization | 140,690 | 4,496 |
Total Expense | 1,105,897 | 873,883 |
Loss from Operations | (1,107,549) | (873,883) |
Penalty on convertible notes | (719,558) | |
Interest expense | (85,221) | (45,766) |
Amortization of debt discount | (22,967) | (263,200) |
Derivative liability movements | 940,750 | 92,161 |
Loss before Income Taxes | (274,987) | (1,810,246) |
Income Taxes | ||
Net Loss | (274,987) | (1,810,246) |
Net loss attributable to non-controlling interest | 1,597 | 8,752 |
Net loss attributable to Innovative Payment Solutions, Inc. stockholders | $ (273,390) | $ (1,801,494) |
Basic and diluted loss per share (in Dollars per share) | $ 0 | $ 0 |
Weighted Average Number of Shares Outstanding - Basic (in Shares) | 376,901,679 | 367,901,679 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Diluted loss per share | $ 0 | $ 0 |
Weighted Average Number of Shares Outstanding – Diluted | 376,901,679 | 376,901,679 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($) | Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Non-controlling shareholders interest | Total |
Balance at Dec. 31, 2021 | $ 36,790 | $ 45,771,012 | $ (42,111,701) | $ 35,211 | $ 3,731,312 | |
Balance (in Shares) at Dec. 31, 2021 | 367,901,679 | |||||
Stock based option expense | 94,466 | 94,466 | ||||
Restricted stock awards | 62,766 | 62,766 | ||||
Net loss | (1,801,494) | (8,752) | (1,810,246) | |||
Balance at Mar. 31, 2022 | $ 36,790 | 45,928,244 | (43,913,195) | 26,459 | 2,078,298 | |
Balance (in Shares) at Mar. 31, 2022 | 367,901,679 | |||||
Balance at Dec. 31, 2022 | $ 37,690 | 48,405,921 | (52,399,858) | 1,597 | (3,954,650) | |
Balance (in Shares) at Dec. 31, 2022 | 376,901,679 | |||||
Fair value of warrants issued | 251,856 | 251,856 | ||||
Stock based option expense | 130,671 | 130,671 | ||||
Net loss | (273,390) | (1,597) | (274,987) | |||
Balance at Mar. 31, 2023 | $ 37,690 | $ 48,788,448 | $ (52,673,248) | $ (3,847,110) | ||
Balance (in Shares) at Mar. 31, 2023 | 376,901,679 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (274,987) | $ (1,810,246) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Derivative liability movements | (940,750) | (92,161) |
Depreciation | 140,690 | 4,496 |
Amortization of debt discount | 22,967 | 263,200 |
Penalty on convertible debt | 719,558 | |
Stock based compensation | 130,671 | 157,232 |
Changes in Assets and Liabilities | ||
Other current assets | 21,957 | 45,708 |
Accounts payable and accrued expenses | 127,311 | (6,221) |
Interest accruals | 83,837 | (42,484) |
CASH USED IN OPERATING ACTIVITIES | (688,304) | (760,918) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Investment in intangibles | (64,783) | (179,030) |
NET CASH USED IN INVESTING ACTIVITIES | (64,783) | (179,030) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from convertible notes | 535,000 | |
Repayment of convertible notes | (1,147,063) | |
Repayment of federal relief loans | (809) | |
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 534,191 | (1,147,063) |
NET DECREASE IN CASH | (218,896) | (2,087,011) |
CASH AT BEGINNING OF PERIOD | 374,765 | 5,449,751 |
CASH AT END OF PERIOD | 155,869 | 3,362,740 |
CASH PAID FOR INTEREST AND TAXES: | ||
Cash paid for income taxes | ||
Cash paid for interest | 1,384 | 88,250 |
NON CASH INVESTING AND FINANCING ACTIVITIES | ||
Fair value of warrants issued with convertible notes | $ 251,856 |
Organization and Description of
Organization and Description of Business | 3 Months Ended |
Mar. 31, 2023 | |
ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract] | |
ORGANIZATION AND DESCRIPTION OF BUSINESS | 1 ORGANIZATION AND DESCRIPTION OF BUSINESS a) Organizational History On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”. Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock. The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes. Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31. On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares. On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California. b) Description of current business The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was fully launched in July 2022 after a soft launch in December 2021. Previously the Company intended to invest in physical kiosks where any payment processing could be undertaken by customers in person. The Company has shifted its business to focus solely on downloadable apps used via smartphones and other online payment processing solutions.. The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired. On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless. |
Accounting Policies and Estimat
Accounting Policies and Estimates | 3 Months Ended |
Mar. 31, 2023 | |
Organization and Description of Business [Abstract] | |
ACCOUNTING POLICIES AND ESTIMATES | 2 ACCOUNTING POLICIES AND ESTIMATES a) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023. All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise. b) Principles of Consolidation The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements. The entities included in the accompanying unaudited condensed consolidated financial statements are as follows: Innovative Payment Solutions, Inc. - Parent Company Beyond Fintech Inc., 51% owned. See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech. c) Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. d) Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed. e) Fair Value of Financial Instruments The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance. ASC 825-10 “ Financial Instruments f) Risks and Uncertainties The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities. The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company. g) Recent accounting pronouncements The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption. h) Reporting by Segment No segmental information is required as the Company only has one operating segment. i) Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively. j) Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022. k) Investments The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income. l) Plant and Equipment Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows: Description Estimated Useful Life Kiosks (not used in the Company’s current business) 7 years Computer equipment 3 years Office equipment 10 years The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. m) Long-Term Assets Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. n) Revenue Recognition The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions: i. identify the contract with a customer; ii. identify the performance obligations in the contract; iii. determine the transaction price; iv. allocate the transaction price to performance obligations in the contract; and v. recognize revenue as the performance obligation is satisfied. The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. o) Share-Based Payment Arrangements Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations. Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available. Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments. Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued. Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements. p) Derivative Liabilities ASC Topic 815, Derivatives and hedging q) Income Taxes The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes. Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes. r) Comprehensive income Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented. |
Liquidity Matters and Going Con
Liquidity Matters and Going Concern | 3 Months Ended |
Mar. 31, 2023 | |
Liquidity Matters [Abstract] | |
LIQUIDITY MATTERS AND GOING CONCERN | 3 LIQUIDITY MATTERS AND GOING CONCERN The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2023 and the year ended December 31, 2022, the Company had a net loss of $274,987 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements. The accompanying financial statements for the three months ended March 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company has determined that there is substantial doubt about their ability to continue as a going concern. |
Intangibles
Intangibles | 3 Months Ended |
Mar. 31, 2023 | |
Intangibles [Abstract] | |
INTANGIBLES | 4 INTANGIBLES On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $41,320 and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless. During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $1,127,400 and $28,893, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. March 31, December 31, Cost Accumulated Net Book Net book Purchase Technology – Beyond Wallet $ 327,211 $ - $ 327,211 $ 291,320 Purchased Technology - IPSIPay 1,531,293 (226,765 ) 1,304,528 1,401,491 $ 1,858,504 $ (226,765 ) $ 1,631,739 $ 1,692,811 Amortization expense was $125,856 and $0 for the three months ended March 31, 2023 and 2022, respectively. |
Investments
Investments | 3 Months Ended |
Mar. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
INVESTMENTS | 5 INVESTMENTS Investment in Frictionless Financial Technologies Inc. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless. The shares in Frictionless are unlisted as of March 31, 2023. March 31, 2023 December 31, Investment in Frictionless Financial Technologies, Inc. $ 500,000 $ 500,000 $ 500,000 $ 500,000 |
Leases
Leases | 3 Months Ended |
Mar. 31, 2023 | |
Disclosure Text Block [Abstract] | |
LEASES | 6 LEASES On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5 th The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred. Total Lease Cost Individual components of the total lease cost incurred by the Company is as follows: Three months Three months Operating lease expense $ 15,264 $ 14,400 Other lease information: Three months Three months Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ (15,264 ) $ (14,400 ) Remaining lease term – operating lease Monthly Monthly |
Federal Relief Loans
Federal Relief Loans | 3 Months Ended |
Mar. 31, 2023 | |
Federal Relief Loans [Abstract] | |
FEDERAL RELIEF LOANS | 7 FEDERAL RELIEF LOANS Small Business Administration Disaster Relief loan On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The Company has repaid an aggregate principal amount of $809 and interest of $1,384 as of March 31, 2023. The loan balance outstanding as of March 31, 2023, consists of principal of $149,191 and accrued interest thereon of $13,978, of which $3,217 is disclosed as current. |
Notes Payable
Notes Payable | 3 Months Ended |
Mar. 31, 2023 | |
Notes Payable [Abstract] | |
NOTES PAYABLE | 8 NOTES PAYABLE On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share. In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance. Notes payable consists of the following: Description Interest Maturity Principal Accrued March 31, 2023 December 31, 2022 Cavalry Fund I LP 10 % December 30, 2023 482,000 12,184 494,184 482,134 Mercer Street Global Opportunity Fund, LLC 10 % December 30, 2023 482,000 12,184 494,184 482,134 Total convertible notes payable $ 964,000 $ 24,368 $ 988,368 $ 964,268 Interest expense totaled $24,100 and $0 for the three months ended March 31, 2023 and 2022, respectively. |
Convertible Notes Payable
Convertible Notes Payable | 3 Months Ended |
Mar. 31, 2023 | |
Convertible Notes Payable [Abstract] | |
CONVERTIBLE NOTES PAYABLE | 9 CONVERTIBLE NOTES PAYABLE December 2022 Note Amendment Transaction On February 16, 2021, we entered into separate SPAs with each of Cavalry and Mercer, pursuant to which we received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.24 per share. Cavalry and Mercer are Selling Stockholders listed in this prospectus. The Original Warrants are discussed in note 8 above. The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under their respective Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price. On December 30, 2022, the Company again extended the maturity dates of each of the Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following: (1) The conversion price of the Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Notes). As a result of this change in conversion price, under the existing terms of the Notes, the 3,000,000 shares of common stock underlying the Extension Warrants was increased to 39,130,435 shares; (2) The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance; (3) Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Notes until after March 30, 2023 and (ii) waive any events of default under the Notes and the SPAs; (4) Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the common stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and (5) The company was obligated to register the shares of common stock underlying the Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation. The parties also acknowledged that the principal and accrued interest under the Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our common stock underlying the Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to the filed registration statement. The amendments to the convertible debt were evaluated in terms of ASC470, Debt, to determine if the amendments to the convertible debt were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the convertible notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the convertible note holders valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (Note 8 above) and the value of full rachet provisions of certain of the warrants issued to the convertible note holders amounting to $841,003, see note 12 below, the amendment of the convertible notes was determined to be a debt extinguishment. Convertible notes payable consists of the following: Description Interest Maturity Principal Accrued Unamortized March 31, 2023 Amount, net December 31, 2022 Amount, net Cavalry Fund I LP 10 % December 30, 1,091,754 68,841 - 1,160,595 1,133,301 Mercer Street Global Opportunity Fund, LLC 10 % December 30, 1,091,754 68,841 - 1,160,595 1,133,301 February 2023 convertible notes 8 % February 13, 2024 535,000 5,149 (228,888 ) 311,261 - Total convertible notes payable $ 2,718,508 $ 142,831 $ (228,888 ) $ 2,632,451 $ 2,266,602 Interest expense totaled $59,737 and $44,379 for the three months ended March 31, 2023 and 2022, respectively. Amortization of debt discount totaled $22,967 and $263,200 for the three months ended March 31, 2023 and 2022, respectively. The Cavalry and Mercer convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the common stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability. Cavalry Fund LLP On February 16, 2021, the Company closed a transaction with Cavalry, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share. As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation. The balance of the Cavalry Note plus accrued interest at March 31, 2023 was $1,160,595. Mercer Street Global Opportunity Fund, LLC On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share. As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation. The balance of the Mercer Note plus accrued interest at March 31, 2023 was $1,160,595. February 2023 convertible notes Between February 13, 2023 and February 23, 2023, the Company, entered into Securities Purchase Agreements (the “Securities Purchase Agreement”) with 11 accredited investors, pursuant to which the Company received an aggregate of $535,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of: ● Convertible Notes Promissory (the “Notes” and each a “Note”); and ● five-year warrants (the “Warrants”) to purchase an aggregate 46,521,739 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale. The Notes and the Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. The balance of the February 2023 Notes plus accrued interest at March 31, 2023 was $311,261, net of unamortized debt discount of $228,888. |
Derivative Liability
Derivative Liability | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVE LIABILITY | 10 DERIVATIVE LIABILITY Certain of the short-term convertible notes disclosed in note 9 above and certain warrants disclosed in note 11 below, have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model. On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 9 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants. The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations. The net movement on the derivative liability for the three months ended March 31, 2023 was a net mark-to-market release of derivative liability of $940,750, determined by using a Black-Scholes valuation model. The following assumptions were used in the Black-Scholes valuation model: Three months ended March 31, 2023 Year ended December 31, 2022 Conversion price $ 0.0115 $ 0.0115 to $0.15 Risk free interest rate 3.60 to 4.79 % 0.79 to 4.73 % Expected life of derivative liability 9 to 53 months 1.5 to 59 months Expected volatility of underlying stock 158.72 to 192.53 % 120.49 to 258.3 % Expected dividend rate 0 % 0 % The movement in derivative liability is as follows: March 31, December 31, Opening balance $ 2,550,642 $ 407,161 Derivative financial liability arising from convertible note and warrants - 238,182 Derivative financial liability arising on note amendment included in loss on convertible notes - 2,317,051 Fair value adjustment to derivative liability (940,750 ) (411,752 ) $ 1,609,892 $ 2,550,642 |
Stockholders_ Equity
Stockholders’ Equity | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS’ EQUITY | 11 STOCKHOLDERS’ EQUITY a. Common Stock The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 376,901,679 shares of Common Stock issued and outstanding as of March 31, 2023 and December 31, 2022, respectively. b. Restricted stock awards A summary of restricted stock activity during the period January 1, 2022 to March 31, 2023 is as follows: Total Weighted Total Weighted Total vested Weighted Outstanding January 1, 2022 21,495,000 $ 0.049 10,247,500 $ 0.049 11,247,500 $ 0.049 Granted and issued 2,000,000 0.055 - - 2,000,000 0.055 Forfeited/Cancelled - - - - - - Vested - - (5,123,750 ) (0.049 ) 5,123,750 0.049 Outstanding December 31, 2022 23,495,000 $ 0.050 5,123,750 $ 0.049 18,371,250 $ 0.050 Granted and issued - - - - - - Forfeited/Cancelled - - - - - - Vested - - (5,123,750 ) (0.049 ) 5,123,750 0.049 Outstanding March 31, 2023 23,495,000 $ 0.050 - $ 0.049 23,495,000 $ 0.050 The restricted stock granted, issued and exercisable at March 31, 2023 is as follows: Restricted Stock Granted and Vested Grant date Price Number Granted Weighted Average Fair Value per Share $ 0.049 20,495,000 $ 0.049 $ 0.050 1,000,000 0.050 $ 0.055 2,000,000 0.055 23,495,000 $ 0.050 The Company has recorded an expense of $0 and $62,766 for the three months March 31, 2023 and 2022, respectively. c. Preferred Stock The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2023 and December 31, 2022. d. Warrants Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services. The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status. As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90 th On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027. On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of common stock in the Company at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. Subsequent to March 31, 2023, the Company entered into an agreement to cancel this warrant (see Note 15). On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ● The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above; ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt. Between February 13, 2023 and February 23, 2023, the Company entered into Securities Purchase Agreements with 11 accredited investors, as disclosed in Note 9 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 46,521,739 shares of the Company’s common stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale. The Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61 st The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions: Three months Exercise price $ 0.0115 Risk free interest rate 3.93 to 4.16 % Expected life 5 years Expected volatility of underlying stock 189.15 to 189.37 % Expected dividend rate 0 % A summary of warrant activity during the period January 1, 2022 to March 31, 2023 is as follows: Shares Exercise Weighted Outstanding January 1, 2022 37,304,105 $ 0.05 – 0.1875 $ 0.12 Granted 51,000,000 0.0115 – 0.0345 0.01826 Increase in warrants due to debt amendment full rachet trigger 72,260,870 0.0115 0.0115 Cancelled on debt amendment (4,973,914 ) 0.15 0.1500 Exercised - - - Outstanding December 31, 2022 155,591,061 $ 0.0115 – 0.1875 $ 0.0300 Granted 46,521,739 0.0115 0.0115 Forfeited (1,000,000 ) 0.05 0.05 Cancelled on debt amendment - - - Exercised - - - Outstanding March 31, 2023 201,112,800 $ 0.0115 – 0.1875 $ 0.0256 The warrants outstanding and exercisable at March 31, 2023 are as follows: Warrants Outstanding Warrants Exercisable Exercise Price Number Weighted Weighted Number Weighted Weighted $ 0.0115 168,519,466 4.48 168,519,466 4.48 $ 0.0345 15,000,000 2.27 10,312,500 2.27 $ 0.15 15,166,667 2.96 15,166,667 2.96 $ 0.1875 2,426,667 2.96 2,426,667 2.96 201,112,800 4.18 $ 0.0256 196,425,300 $ 0.0256 4.23 The warrants outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022. e. Stock options On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028. The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan. The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock. On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031. The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan. The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock. Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards. On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022. On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022. A summary of option activity during the period January 1, 2022 to March 31, 2023 is as follows: Shares Exercise Weighted Outstanding January 1, 2022 30,516,666 $ 0.15 to 0.40 $ 0.15 Granted 15,800,000 0.04 – 0.15 0.14 Forfeited/Cancelled - - - Exercised - - - Outstanding December 31, 2022 46,316,666 $ 0.04 to 0.40 $ 0.15 Granted - - - Forfeited/Cancelled - - - Exercised - - - Outstanding March 31, 2023 46,316,666 $ 0.04 to 0.40 $ 0.15 The options outstanding and exercisable at March 31, 2023 are as follows: Options Outstanding Options Exercisable Exercise Price Number Weighted Weighted Number Weighted Weighted $ 0.04 800,000 9.46 800,000 9.46 $ 0.15 45,208,333 8.69 38,125,000 8.74 $ 0.24 208,333 7.90 208,333 7.90 $ 0.40 100,000 5.75 100,000 5.75 46,316,666 8.69 $ 0.15 39,233,333 $ 0.15 8.75 The options outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022. The option expense was $94,464 and $94,466 for the three months ended March 31, 2023 and 2022, respectively. |
Net Loss Per Share
Net Loss Per Share | 3 Months Ended |
Mar. 31, 2023 | |
Net Loss Per Share [Abstract] | |
NET LOSS PER SHARE | 12 NET LOSS PER SHARE Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share. Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2023 and 2022 are as follows: Three months ended Three months ended Convertible debt 248,812,128 11,687,855 Stock options 46,316,666 30,516,666 Warrants to purchase shares of Common Stock 201,112,800 37,304,104 496,241,594 79,508,625 |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | 13 RELATED PARTY TRANSACTIONS The following transactions were entered into with related parties: James Fuller On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share. The option expense for Mr. Fuller was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively. Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022. William Corbett On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share. The option expense for Mr. Corbett was $66,587 and $1,090,201 for the three months ended March 31, 2023 and the year ended December 31, 20221, respectively. Clifford Henry Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022. On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model. The option expense for Mr. Henry was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively. Madisson Corbett On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model. The option expense for Ms. Corbett was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively. David Rios On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model. The option expense for Mr. Rios was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively. Richard Rosenblum On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested. The option expense for Mr. Rosenblum was $27,879 and $111,514 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | 14 COMMITMENTS AND CONTINGENCIES The Company has notes payable and convertible notes payable, disclosed under note 8 and 9 above, which mature between December 30, 2023 and February 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | 15 SUBSEQUENT EVENTS On April 28, 2023, the Company formed a new Delaware limited liability company called IPSIPay Express LLC. This entity was formed as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. As of the date of issuance of these financial statements, definitive documentation memorializing the joint venture are being finalized. On May 10, 2023, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which the Company issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to the Company of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. The Company is required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion. On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Organization and Description of Business [Abstract] | |
Basis of Presentation | a) Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023. All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise. |
Principles of Consolidation | b) Principles of Consolidation The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements. The entities included in the accompanying unaudited condensed consolidated financial statements are as follows: Innovative Payment Solutions, Inc. - Parent Company Beyond Fintech Inc., 51% owned. See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech. |
Use of Estimates | c) Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. |
Contingencies | d) Contingencies Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed. |
Fair Value of Financial Instruments | e) Fair Value of Financial Instruments The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance. ASC 825-10 “ Financial Instruments |
Risks and Uncertainties | f) Risks and Uncertainties The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities. The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company. |
Recent accounting pronouncements | g) Recent accounting pronouncements The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption. |
Reporting by Segment | h) Reporting by Segment No segmental information is required as the Company only has one operating segment. |
Cash and Cash Equivalents | i) Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively. |
Accounts Receivable and Allowance for Doubtful Accounts | j) Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022. |
Investments | k) Investments The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income. |
Plant and Equipment | l) Plant and Equipment Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows: Description Estimated Useful Life Kiosks (not used in the Company’s current business) 7 years Computer equipment 3 years Office equipment 10 years The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. |
Long-Term Assets | m) Long-Term Assets Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. |
Revenue Recognition | n) Revenue Recognition The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions: i. identify the contract with a customer; ii. identify the performance obligations in the contract; iii. determine the transaction price; iv. allocate the transaction price to performance obligations in the contract; and v. recognize revenue as the performance obligation is satisfied. The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. |
Share-Based Payment Arrangements | o) Share-Based Payment Arrangements Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations. Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available. Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments. Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued. Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements. |
Derivative Liabilities | p) Derivative Liabilities ASC Topic 815, Derivatives and hedging |
Income Taxes | q) Income Taxes The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes. Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes. |
Comprehensive income | r) Comprehensive income Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented. |
Accounting Policies and Estim_2
Accounting Policies and Estimates (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Organization and Description of Business [Abstract] | |
Schedule of estimated useful lives of the assets | Description Estimated Useful Life Kiosks (not used in the Company’s current business) 7 years Computer equipment 3 years Office equipment 10 years |
Intangibles (Tables)
Intangibles (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Intangibles Table [Abstract] | |
Schedule of facilitate the functioning of the IPSIPay software | March 31, December 31, Cost Accumulated Net Book Net book Purchase Technology – Beyond Wallet $ 327,211 $ - $ 327,211 $ 291,320 Purchased Technology - IPSIPay 1,531,293 (226,765 ) 1,304,528 1,401,491 $ 1,858,504 $ (226,765 ) $ 1,631,739 $ 1,692,811 |
Investments (Tables)
Investments (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
Schedule of investment | March 31, 2023 December 31, Investment in Frictionless Financial Technologies, Inc. $ 500,000 $ 500,000 $ 500,000 $ 500,000 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Disclosure Text Block [Abstract] | |
Schedule of total lease cost | Three months Three months Operating lease expense $ 15,264 $ 14,400 |
Schedule of other lease information | Three months Three months Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ (15,264 ) $ (14,400 ) Remaining lease term – operating lease Monthly Monthly |
Notes Payable (Tables)
Notes Payable (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Payable [Abstract] | |
Schedule of notes payable | Description Interest Maturity Principal Accrued March 31, 2023 December 31, 2022 Cavalry Fund I LP 10 % December 30, 2023 482,000 12,184 494,184 482,134 Mercer Street Global Opportunity Fund, LLC 10 % December 30, 2023 482,000 12,184 494,184 482,134 Total convertible notes payable $ 964,000 $ 24,368 $ 988,368 $ 964,268 |
Convertible Notes Payable (Tabl
Convertible Notes Payable (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Convertible Notes Payable [Abstract] | |
Schedule of convertible notes payable | Description Interest Maturity Principal Accrued Unamortized March 31, 2023 Amount, net December 31, 2022 Amount, net Cavalry Fund I LP 10 % December 30, 1,091,754 68,841 - 1,160,595 1,133,301 Mercer Street Global Opportunity Fund, LLC 10 % December 30, 1,091,754 68,841 - 1,160,595 1,133,301 February 2023 convertible notes 8 % February 13, 2024 535,000 5,149 (228,888 ) 311,261 - Total convertible notes payable $ 2,718,508 $ 142,831 $ (228,888 ) $ 2,632,451 $ 2,266,602 |
Derivative Liability (Tables)
Derivative Liability (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of assumptions were used in the black-scholes valuation model | Three months ended March 31, 2023 Year ended December 31, 2022 Conversion price $ 0.0115 $ 0.0115 to $0.15 Risk free interest rate 3.60 to 4.79 % 0.79 to 4.73 % Expected life of derivative liability 9 to 53 months 1.5 to 59 months Expected volatility of underlying stock 158.72 to 192.53 % 120.49 to 258.3 % Expected dividend rate 0 % 0 % |
Schedule of movement in derivative liability | March 31, December 31, Opening balance $ 2,550,642 $ 407,161 Derivative financial liability arising from convertible note and warrants - 238,182 Derivative financial liability arising on note amendment included in loss on convertible notes - 2,317,051 Fair value adjustment to derivative liability (940,750 ) (411,752 ) $ 1,609,892 $ 2,550,642 |
Stockholders_ Equity (Tables)
Stockholders’ Equity (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of restricted stock activity | Total Weighted Total Weighted Total vested Weighted Outstanding January 1, 2022 21,495,000 $ 0.049 10,247,500 $ 0.049 11,247,500 $ 0.049 Granted and issued 2,000,000 0.055 - - 2,000,000 0.055 Forfeited/Cancelled - - - - - - Vested - - (5,123,750 ) (0.049 ) 5,123,750 0.049 Outstanding December 31, 2022 23,495,000 $ 0.050 5,123,750 $ 0.049 18,371,250 $ 0.050 Granted and issued - - - - - - Forfeited/Cancelled - - - - - - Vested - - (5,123,750 ) (0.049 ) 5,123,750 0.049 Outstanding March 31, 2023 23,495,000 $ 0.050 - $ 0.049 23,495,000 $ 0.050 |
Schedule of restricted stock granted and exercisable | Restricted Stock Granted and Vested Grant date Price Number Granted Weighted Average Fair Value per Share $ 0.049 20,495,000 $ 0.049 $ 0.050 1,000,000 0.050 $ 0.055 2,000,000 0.055 23,495,000 $ 0.050 |
Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model | Three months Exercise price $ 0.0115 Risk free interest rate 3.93 to 4.16 % Expected life 5 years Expected volatility of underlying stock 189.15 to 189.37 % Expected dividend rate 0 % |
Schedule of warrant activity | Shares Exercise Weighted Outstanding January 1, 2022 37,304,105 $ 0.05 – 0.1875 $ 0.12 Granted 51,000,000 0.0115 – 0.0345 0.01826 Increase in warrants due to debt amendment full rachet trigger 72,260,870 0.0115 0.0115 Cancelled on debt amendment (4,973,914 ) 0.15 0.1500 Exercised - - - Outstanding December 31, 2022 155,591,061 $ 0.0115 – 0.1875 $ 0.0300 Granted 46,521,739 0.0115 0.0115 Forfeited (1,000,000 ) 0.05 0.05 Cancelled on debt amendment - - - Exercised - - - Outstanding March 31, 2023 201,112,800 $ 0.0115 – 0.1875 $ 0.0256 |
Schedule of warrants outstanding and exercisable | Warrants Outstanding Warrants Exercisable Exercise Price Number Weighted Weighted Number Weighted Weighted $ 0.0115 168,519,466 4.48 168,519,466 4.48 $ 0.0345 15,000,000 2.27 10,312,500 2.27 $ 0.15 15,166,667 2.96 15,166,667 2.96 $ 0.1875 2,426,667 2.96 2,426,667 2.96 201,112,800 4.18 $ 0.0256 196,425,300 $ 0.0256 4.23 |
Schedule of option activity | Shares Exercise Weighted Outstanding January 1, 2022 30,516,666 $ 0.15 to 0.40 $ 0.15 Granted 15,800,000 0.04 – 0.15 0.14 Forfeited/Cancelled - - - Exercised - - - Outstanding December 31, 2022 46,316,666 $ 0.04 to 0.40 $ 0.15 Granted - - - Forfeited/Cancelled - - - Exercised - - - Outstanding March 31, 2023 46,316,666 $ 0.04 to 0.40 $ 0.15 |
Schedule of options outstanding and exercisable | Options Outstanding Options Exercisable Exercise Price Number Weighted Weighted Number Weighted Weighted $ 0.04 800,000 9.46 800,000 9.46 $ 0.15 45,208,333 8.69 38,125,000 8.74 $ 0.24 208,333 7.90 208,333 7.90 $ 0.40 100,000 5.75 100,000 5.75 46,316,666 8.69 $ 0.15 39,233,333 $ 0.15 8.75 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Net Loss Per Share [Abstract] | |
Schedule of dilutive shares | Three months ended Three months ended Convertible debt 248,812,128 11,687,855 Stock options 46,316,666 30,516,666 Warrants to purchase shares of Common Stock 201,112,800 37,304,104 496,241,594 79,508,625 |
Organization and Description _2
Organization and Description of Business (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |||||
Dec. 31, 2019 | Aug. 26, 2021 | Mar. 31, 2023 | Aug. 30, 2022 | Jun. 22, 2021 | Feb. 16, 2021 | Nov. 01, 2019 | |
Organization and Description of Business (Textual) | |||||||
Shares of Common Stock (in Shares) | 621,920 | ||||||
Aggregate shares of Common Stock (in Shares) | 2,500 | 51,901,711 | |||||
Retained shares of Common Stock (in Dollars) | $ 500,000 | ||||||
Outstanding shares of Common Stock (in Shares) | 32,047,817 | ||||||
Exchange shares (in Shares) | 2,250,000 | ||||||
Stock purchase agreement (in Shares) | 2,250,000 | ||||||
Shares of vivi | 9% | ||||||
Percentage of remaining shares owned | 49% | ||||||
Beyond Fintech [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Stake owned percentage | 51% | ||||||
Common Stock [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Common stock, par value (in Dollars per share) | $ 0.0001 | ||||||
Shares of Common Stock (in Shares) | 500,000 | ||||||
Aggregate shares of Common Stock (in Shares) | 3,000,000 | ||||||
Outstanding Common Stock percentage | 91% | ||||||
Outstanding shares of Common Stock (in Shares) | 320,477,867 | ||||||
Frictionless Financial Technologies, Inc. [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Acquired percentage | 1% | ||||||
Frictionless [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Strategic interest | 10% | ||||||
Common stock outstanding percentage | 41% | ||||||
Purchase price (in Dollars) | $ 300,000 | ||||||
Qpagos Corporation’s Capital Stock [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Shares of Common Stock (in Shares) | 4,992,900 | ||||||
Qpagos Corporation’s Capital Stock [Member] | Common Stock [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Shares of Common Stock (in Shares) | 497,500 | ||||||
Gaston Pereira [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Shares of vivi | 5% | ||||||
Andrey Novikov [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Shares of vivi | 2.50% | ||||||
Joseph Abrams [Member] | |||||||
Organization and Description of Business (Textual) | |||||||
Shares of vivi | 1.50% |
Accounting Policies and Estim_3
Accounting Policies and Estimates (Details) | 3 Months Ended | ||
Mar. 31, 2023 USD ($) | Mar. 31, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
Accounting Policies and Estimates (Textual) | |||
Ownership percentage | 20% | ||
Operating segment | 1 | ||
Federally insured limit | $ 0 | $ 120,580 | |
Plant and equipment costs | 1,000 | ||
Revenues | $ 433 | $ 0 | |
Beyond Fintech Inc. [Member] | |||
Accounting Policies and Estimates (Textual) | |||
Ownership percentage | 51% |
Accounting Policies and Estim_4
Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets | Mar. 31, 2023 |
Kiosks [Member] | |
Estimated useful lives | 7 years |
Computer equipment [Member] | |
Estimated useful lives | 3 years |
Office equipment [Member] | |
Estimated useful lives | 10 years |
Liquidity Matters and Going C_2
Liquidity Matters and Going Concern (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Liquidity Matters (Textual) | ||
Net loss | $ 274,987 | $ 10,331,424 |
Intangibles (Details)
Intangibles (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Aug. 26, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Gross proceeds | $ 250,000 | $ 375,000 | |||
Beyond fintech percentage | 51% | ||||
Owned frictionless percentage | 49% | ||||
Additional amount of software | $ 35,891 | $ 41,320 | |||
IPSIPay software amount | 28,893 | $ 1,127,400 | |||
Amortization expense | $ 125,856 | $ 0 |
Intangibles (Details) - Schedul
Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Schedule of facilitate the functioning of the IPSIPay software [Abstract] | ||
Cost | $ 1,858,504 | |
Accumulated amortization | (226,765) | |
Net Book Value | 1,631,739 | $ 1,692,811 |
Purchase Technology – Beyond Wallet [Member] | ||
Schedule of facilitate the functioning of the IPSIPay software [Abstract] | ||
Cost | 327,211 | |
Accumulated amortization | ||
Net Book Value | 327,211 | 291,320 |
Purchased Technology - IPSIPay [Member] | ||
Schedule of facilitate the functioning of the IPSIPay software [Abstract] | ||
Cost | 1,531,293 | |
Accumulated amortization | (226,765) | |
Net Book Value | $ 1,304,528 | $ 1,401,491 |
Investments (Details)
Investments (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Investment (Textual) | |
Right to acquire percentage | 1% |
Frictionless Financial Technologies, Inc.[Member] | |
Investment (Textual) | |
Right to acquire percentage | 41% |
Purchase price (in Dollars) | $ 300,000 |
Investments (Details) - Schedul
Investments (Details) - Schedule of investment - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Investments (Details) - Schedule of investment [Line Items] | ||
Investment | $ 500,000 | $ 500,000 |
Investment in Frictionless Financial Technologies, Inc. [Member] | ||
Investments (Details) - Schedule of investment [Line Items] | ||
Investment | $ 500,000 | $ 500,000 |
Leases (Details)
Leases (Details) - USD ($) | 3 Months Ended | |
Jan. 01, 2023 | Mar. 31, 2023 | |
Leases (Textual) | ||
Lease, description | The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. | |
Lease amount | $ 4,800 | |
Monthly rent | $ 5,088 |
Leases (Details) - Schedule of
Leases (Details) - Schedule of total lease cost - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Schedule of total lease cost [Abstract] | ||
Operating lease expense | $ 15,264 | $ 14,400 |
Leases (Details) - Schedule o_2
Leases (Details) - Schedule of other lease information - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Cash paid for amounts included in the measurement of lease liabilities | ||
Operating cash flows from operating leases | $ (15,264) | $ (14,400) |
Remaining lease term – operating lease | Monthly | Monthly |
Federal Relief Loans (Details)
Federal Relief Loans (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |
Jul. 07, 2020 | Feb. 16, 2021 | Mar. 31, 2023 | |
Federal Relief Loans [Abstract] | |||
Disaster loan amount | $ 150,000 | ||
Bearing interest, percentage | 3.75% | ||
Repayable installments | $ 731 | ||
Aggregate principal amount | $ 572,000 | $ 809 | |
Aggregate principal amount interest | 1,384 | ||
Loan balance outstanding | 149,191 | ||
Accrued interest | 13,978 | ||
Disclosed amount of accrued interest | $ 3,217 |
Notes Payable (Details)
Notes Payable (Details) - USD ($) | 3 Months Ended | ||
Feb. 16, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | |
Notes Payable (Details) [Line Items] | |||
Company received | $ 500,500 | ||
Interest rate | 12.50% | ||
Common stock, shares (in Shares) | 2,486,957 | ||
Exercise price per share (in Dollars per share) | $ 0.24 | ||
Promissory note | $ 482,000 | ||
Notes issued | 964,000 | ||
Fair value of the warrants | 43,608 | ||
Convertible debt | $ 920,392 | ||
Interest expense | $ 24,100 | $ 0 | |
December 30, 2022 Note [Member] | |||
Notes Payable (Details) [Line Items] | |||
Interest rate | 10% | ||
Common stock, shares (in Shares) | 51,901,711 | ||
Promissory note | $ 482,000 | ||
Maturity date | Dec. 30, 2023 | ||
Cavalry and Mercer [Member] | |||
Notes Payable (Details) [Line Items] | |||
Company received | $ 500,500 | ||
Principal amount | $ 572,000 |
Notes Payable (Details) - Sched
Notes Payable (Details) - Schedule of notes payable - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Notes Payable (Details) - Schedule of notes payable [Line Items] | ||
Principal | $ 964,000 | |
Accrued Interest | 24,368 | |
Amount, net | $ 988,368 | $ 964,268 |
Cavalry Fund I LP [Member] | ||
Notes Payable (Details) - Schedule of notes payable [Line Items] | ||
Interest Rate | 10% | |
Maturity date | December 30, 2023 | |
Principal | $ 482,000 | |
Accrued Interest | 12,184 | |
Amount, net | $ 494,184 | 482,134 |
Mercer Street Global Opportunity Fund, LLC [Member] | ||
Notes Payable (Details) - Schedule of notes payable [Line Items] | ||
Interest Rate | 10% | |
Maturity date | December 30, 2023 | |
Principal | $ 482,000 | |
Accrued Interest | 12,184 | |
Amount, net | $ 494,184 | $ 482,134 |
Convertible Notes Payable (Deta
Convertible Notes Payable (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
Feb. 03, 2022 | Feb. 23, 2023 | Feb. 13, 2023 | Dec. 28, 2022 | Nov. 16, 2022 | Feb. 16, 2021 | Mar. 31, 2023 | Dec. 31, 2022 | |
Convertible Notes Payable (Textual) | ||||||||
Net proceeds | $ 500,500 | |||||||
Principal amount | $ 572,000 | $ 809 | ||||||
Common stock shares (in Shares) | 2,486,957 | 3,000,000 | ||||||
Exercise price per share (in Dollars per share) | $ 0.0115 | $ 0.24 | $ 0.0115 | |||||
Maturity date | Aug. 16, 2022 | Dec. 30, 2023 | ||||||
Interest rate | 10% | 8% | ||||||
Purchase of additional shares (in Shares) | 3,000,000 | |||||||
Warrant exercisable (in Shares) | 39,130,435 | |||||||
Non-convertible promissory notes | $ 482,000 | |||||||
Common stock shares issued (in Shares) | 51,901,711 | 2,500 | ||||||
Common stock price per share (in Dollars per share) | $ 0.06 | |||||||
Aggregate amount | $ 2,264,784 | |||||||
Convertible notes | $ 836,414 | |||||||
Black-scholes valuation model | 1,499,577 | |||||||
Convertible note holders | 238,182 | |||||||
Additional charge | 920,392 | |||||||
Warrant cost | 43,608 | |||||||
Value of notes | 964,000 | |||||||
Holders amount | 841,003 | |||||||
Interest expense | 59,737 | $ 44,379 | ||||||
Amortization of debt discount | 22,967 | 263,200 | ||||||
Accrued interest and penalty interest | 311,261 | |||||||
Gross proceeds | $ 535,000 | $ 535,000 | ||||||
Purchase of aggregate shares | $ 46,521,739 | |||||||
Conversion price of per share (in Dollars per share) | $ 0.0115 | |||||||
Beneficially own of percentage | 4.99% | |||||||
Limitation exceeds of percentage | 9.99% | |||||||
Net of unamortized debt discount | $ 228,888 | $ 0 | ||||||
Cavalry Fund I LP [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Net proceeds | $ 500,500 | |||||||
Original issue discount | $ 71,500 | |||||||
Exercise price per share (in Dollars per share) | $ 0.15 | $ 0.24 | ||||||
Interest rate | 20% | 10% | ||||||
Warrant exercisable (in Shares) | 2,486,957 | |||||||
Senior secured convertible note | $ 572,000 | |||||||
Initial conversion price per share (in Dollars per share) | $ 0.23 | |||||||
Purchase an additional shares (in Shares) | 3,000,000 | |||||||
Conversion price (in Dollars per share) | $ 1,160,595 | |||||||
Mercer Street Global Opportunity Fund, LLC [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Net proceeds | $ 500,500 | |||||||
Original issue discount | $ 572,000 | |||||||
Exercise price per share (in Dollars per share) | $ 0.15 | $ 0.24 | ||||||
Interest rate | 20% | |||||||
Warrant exercisable (in Shares) | 2,486,957 | |||||||
Senior secured convertible note | $ 71,500 | |||||||
Purchase an additional shares (in Shares) | 3,000,000 | |||||||
Conversion price (in Dollars per share) | $ 0.23 | |||||||
Original issue discount rate | 10% | |||||||
Accrued interest and penalty interest | $ 1,160,595 | |||||||
Minimum [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | $ 0.15 | |||||||
Minimum [Member] | Cavalry Fund I LP [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | $ 0.15 | |||||||
Minimum [Member] | Mercer Street Global Opportunity Fund, LLC [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | 0.15 | |||||||
Maximum [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | 0.0115 | |||||||
Maximum [Member] | Cavalry Fund I LP [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | 0.0115 | |||||||
Maximum [Member] | Mercer Street Global Opportunity Fund, LLC [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | $ 0.0115 | |||||||
Cavalry and Mercer [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Net proceeds | $ 500,500 | |||||||
Original issue discount | $ 12.5 | |||||||
Exercise price per share (in Dollars per share) | $ 0.15 | 0.04 | ||||||
Interest rate | 20% | |||||||
Aggregate amount | $ 1,132,392 | |||||||
Cavalry and Mercer [Member] | Minimum [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | 0.15 | |||||||
Cavalry and Mercer [Member] | Maximum [Member] | ||||||||
Convertible Notes Payable (Textual) | ||||||||
Conversion price, per share (in Dollars per share) | $ 0.0115 |
Convertible Notes Payable (De_2
Convertible Notes Payable (Details) - Schedule of convertible notes payable - Construction Loan Payable [Member] - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Principal | $ 2,718,508 | |
Accrued Interest | 142,831 | |
Unamortized debt discount | (228,888) | |
Convertible notes payable | $ 2,632,451 | $ 2,266,602 |
Cavalry Fund I LP [Member] | ||
Interest Rate | 10% | |
Maturity date | December 30, 2023 | |
Principal | $ 1,091,754 | |
Accrued Interest | 68,841 | |
Unamortized debt discount | ||
Convertible notes payable | $ 1,160,595 | 1,133,301 |
Mercer Street Global Opportunity Fund, LLC [Member] | ||
Interest Rate | 10% | |
Maturity date | December 30, 2023 | |
Principal | $ 1,091,754 | |
Accrued Interest | 68,841 | |
Unamortized debt discount | ||
Convertible notes payable | $ 1,160,595 | 1,133,301 |
February 2023 convertible notes [Member] | ||
Interest Rate | 8% | |
Maturity date | February 13, 2024 to February 23, 2024 | |
Principal | $ 535,000 | |
Accrued Interest | 5,149 | |
Unamortized debt discount | (228,888) | |
Convertible notes payable | $ 311,261 |
Derivative Liability (Details)
Derivative Liability (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Derivative Liability (Textual) | |
Rachet provision | $ 474,614 |
Derivative liability | 940,750 |
Cavalry and Mercer [Member] | |
Derivative Liability (Textual) | |
Derivative liability | $ 2,317,051 |
Derivative Liability (Details)
Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Conversion price (in Dollars per share) | $ 0.0115 | |
Expected dividend rate | 0% | 0% |
Minimum [Member] | ||
Conversion price (in Dollars per share) | $ 0.0115 | |
Risk free interest rate | 3.60% | 0.79% |
Expected life of derivative liability | 9 years | 1 year 6 months |
Expected volatility of underlying stock | 158.72% | 120.49% |
Maximum [Member] | ||
Conversion price (in Dollars per share) | $ 0.15 | |
Risk free interest rate | 4.79% | 4.73% |
Expected life of derivative liability | 53 years | 59 years |
Expected volatility of underlying stock | 192.53% | 258.30% |
Derivative Liability (Details_2
Derivative Liability (Details) - Schedule of movement in derivative liability - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Opening balance | $ 2,550,642 | $ 407,161 |
Derivative financial liability arising from convertible note and warrants | 238,182 | |
Derivative financial liability arising on note amendment included in loss on convertible notes | 2,317,051 | |
Fair value adjustment to derivative liability | (940,750) | (411,752) |
Total | $ 1,609,892 | $ 2,550,642 |
Stockholders_ Equity (Details)
Stockholders’ Equity (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||
Sep. 13, 2022 | Jul. 11, 2022 | Dec. 31, 2019 | Dec. 30, 2022 | Aug. 30, 2022 | Aug. 30, 2022 | Feb. 23, 2021 | Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | Feb. 16, 2021 | |
Stockholders' Equity (Textual) | |||||||||||
Common Stock, Shares Authorized | 750,000,000 | 750,000,000 | |||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||
Common Stock, Shares, Issued | 376,901,679 | 376,901,679 | |||||||||
Common Stock, Shares, Outstanding | 376,901,679 | 376,901,679 | |||||||||
Other Tax Expense (Benefit) (in Dollars) | $ 0 | $ 62,766 | |||||||||
Preferred stock, authorized | 25,000,000 | 25,000,000 | |||||||||
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||
Description of compensation service | (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. | ||||||||||
Shares of Common Stock | 2,500 | 51,901,711 | |||||||||
Expiration Date | Aug. 30, 2027 | ||||||||||
Purchased shares | 2,250,000 | ||||||||||
Exercise price (in Dollars per share) | $ 0.04 | ||||||||||
Note amendment transaction description | the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ● The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above; ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt. | ||||||||||
Limitation exceeds percentage | 9.99% | ||||||||||
Warrants outstanding an intrinsic value (in Dollars) | $ 0 | 0 | |||||||||
Incentive stock options | 201,112,800 | ||||||||||
Amount of immediate expense (in Dollars) | $ 31,970 | ||||||||||
Options exercisable shares | 200,000 | ||||||||||
Intrinsic value outstanding options (in Dollars) | $ 0 | 0 | |||||||||
Option expense (in Dollars) | $ 94,464 | $ 94,466 | |||||||||
Common Stock [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Shares of Common Stock | 3,000,000 | 3,000,000 | |||||||||
Exercise price (in Dollars per share) | $ 0.15 | ||||||||||
Exercise price (in Dollars per share) | $ 0.0115 | ||||||||||
Options exercisable shares | 800,000 | ||||||||||
Warrant [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Purchased shares | 30,000,000 | ||||||||||
Fair value of warrants (in Dollars) | $ 348,938 | ||||||||||
Maximum [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Shares of Common Stock | 800,000 | ||||||||||
Maximum [Member] | Common Stock [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Shares of Common Stock | 100,000 | ||||||||||
Maximum [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Warrants beneficially percentage | 4.99% | ||||||||||
Chief Executive Officer [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Incentive stock options | 15,000,000 | ||||||||||
Stock option exercise price (in Dollars per share) | $ 0.15 | ||||||||||
Amount of immediate expense (in Dollars) | $ 823,854 | ||||||||||
Debt Conversion Notices [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Aggregate shares of common stock | 46,521,739 | ||||||||||
Convertible debt amount (in Dollars) | $ 0.0115 | ||||||||||
2021 Stock Incentive Plan [Member] | Maximum [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Shares of Common Stock | 53,000,000 | ||||||||||
2018 Stock Incentive Plan [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Terminates period | 10 years | ||||||||||
2021 Stock Incentive Plan [Member] | |||||||||||
Stockholders' Equity (Textual) | |||||||||||
Terminates period | 10 years |
Stockholders_ Equity (Details)
Stockholders’ Equity (Details) - Schedule of restricted stock activity - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Total restricted shares [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Total restricted shares, Outstanding at beginning (in Shares) | 23,495,000 | 21,495,000 |
Total restricted shares, Outstanding at beginning (in Shares) | 23,495,000 | 23,495,000 |
Total restricted shares, Granted and issued (in Shares) | 2,000,000 | |
Total restricted shares, Forfeited/Cancelled (in Shares) | ||
Total restricted shares, Vested (in Shares) | ||
Weighted average fair market value per share [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Weighted average fair market value per share, Outstanding at ending | $ 0.05 | $ 0.049 |
Weighted average fair market value per share, Outstanding at ending | 0.05 | 0.05 |
Weighted average fair market value per share, Granted and issued | 0.055 | |
Weighted average fair market value per share, Forfeited/Cancelled | ||
Weighted average fair market value per share, Vested | ||
Total unvested restricted shares [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Total unvested restricted shares, Outstanding at ending (in Shares) | 5,123,750 | 10,247,500 |
Total unvested restricted shares, Outstanding at ending (in Shares) | 5,123,750 | |
Total unvested restricted shares, Granted and issued (in Shares) | ||
Total unvested restricted shares, Forfeited/Cancelled (in Shares) | ||
Total unvested restricted shares, Vested (in Shares) | (5,123,750) | (5,123,750) |
Unvested restricted Weighted average fair market value per share [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Weighted average fair market value per share, Outstanding at ending | $ 0.049 | $ 0.049 |
Weighted average fair market value per share, Outstanding at ending | 0.049 | 0.049 |
Weighted average fair market value per share, Granted and issued | ||
Weighted average fair market value per share, Forfeited/Cancelled | ||
Weighted average fair market value per share, Vested | (0.049) | (0.049) |
Total vested restricted shares [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Total vested restricted shares, Outstanding at ending | 18,371,250 | 11,247,500 |
Total vested restricted shares, Outstanding at ending | 23,495,000 | 18,371,250 |
Total vested restricted shares, Granted and issued | 2,000,000 | |
Total vested restricted shares, Forfeited/Cancelled | ||
Total vested restricted shares, Vested | 5,123,750 | 5,123,750 |
Vested restricted Weighted average fair market value per share [Member] | ||
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items] | ||
Weighted average fair market value per share, Outstanding at ending | 0.05 | 0.049 |
Weighted average fair market value per share, Outstanding at ending | 0.05 | 0.05 |
Weighted average fair market value per share, Granted and issued | 0.055 | |
Weighted average fair market value per share, Forfeited/Cancelled | ||
Weighted average fair market value per share, Vested | $ 0.049 | $ 0.049 |
Stockholders_ Equity (Details_2
Stockholders’ Equity (Details) - Schedule of restricted stock granted and exercisable | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Restricted stock granted, number granted | shares | 23,495,000 |
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares | $ 0.05 |
Grant date Price 0.049 [Member] | |
Restricted stock granted, number granted | shares | 20,495,000 |
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares | $ 0.049 |
Grant date Price 0.050 [Member] | |
Restricted stock granted, number granted | shares | 1,000,000 |
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares | $ 0.05 |
Grant date Price 0.055 [Member] | |
Restricted stock granted, number granted | shares | 2,000,000 |
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares | $ 0.055 |
Stockholders_ Equity (Details_3
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model - Warrants [Member] | 3 Months Ended |
Mar. 31, 2023 $ / shares | |
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items] | |
Exercise price (in Dollars per share) | $ 0.0115 |
Expected life | 5 years |
Expected dividend rate | 0% |
Minimum [Member] | |
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items] | |
Risk free interest rate | 3.93% |
Expected volatility of underlying stock | 189.15% |
Maximum [Member] | |
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items] | |
Risk free interest rate | 4.16% |
Expected volatility of underlying stock | 189.37% |
Stockholders_ Equity (Details_4
Stockholders’ Equity (Details) - Schedule of warrant activity - Warrant [Member] - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Product Warranty Liability [Line Items] | ||
Shares Underlying Warrants, Outstanding at beginning (in Shares) | 155,591,061 | 37,304,105 |
Weighted average exercise price, Outstanding at ending | $ 0.03 | $ 0.12 |
Shares Underlying Warrants, Outstanding at beginning (in Shares) | 201,112,800 | 155,591,061 |
Weighted average exercise price, Outstanding at ending | $ 0.0256 | $ 0.03 |
Shares Underlying Warrants, Granted (in Shares) | 46,521,739 | 51,000,000 |
Exercise price per share, Granted | $ 0.0115 | |
Weighted average exercise price, Granted | $ 0.0115 | $ 0.01826 |
Shares Underlying Warrants, Forfeited (in Shares) | (1,000,000) | |
Exercise price per share, Forfeited | $ 0.05 | |
Weighted average exercise price, Forfeited | $ 0.05 | |
Shares Underlying Warrants, Increase in warrants due to debt amendment full rachet trigger (in Shares) | 72,260,870 | |
Exercise price per share, Increase in warrants due to debt amendment full rachet trigger | $ 0.0115 | |
Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger | $ 0.0115 | |
Shares Underlying Warrants, Cancelled on debt amendment (in Shares) | (4,973,914) | |
Exercise price per share, Cancelled on debt amendment | $ 0.15 | |
Weighted average exercise price, Cancelled on debt amendment | $ 0.15 | |
Shares Underlying Warrants, Exercised (in Shares) | ||
Exercise price per share, Exercised | ||
Weighted average exercise price, Exercised | ||
Minimum [Member] | ||
Product Warranty Liability [Line Items] | ||
Exercise price per share, Outstanding at ending | 0.0115 | 0.05 |
Exercise price per share, Outstanding at ending | 0.0115 | 0.0115 |
Exercise price per share, Granted | 0.0115 | |
Maximum [Member] | ||
Product Warranty Liability [Line Items] | ||
Exercise price per share, Outstanding at ending | 0.1875 | 0.1875 |
Exercise price per share, Outstanding at ending | $ 0.1875 | 0.1875 |
Exercise price per share, Granted | $ 0.0345 |
Stockholders_ Equity (Details_5
Stockholders’ Equity (Details) - Schedule of warrants outstanding and exercisable | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Warrants Outstanding, Number Outstanding | 201,112,800 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 years 2 months 4 days |
Warrants Outstanding, Weighted Average Exercise Price | $ / shares | $ 0.0256 |
Warrants Exercisable, Number Exercisable | 196,425,300 |
Warrants Exercisable ,Weighted Average Exercise Price | $ / shares | $ 0.0256 |
Warrants Exercisable, Weighted Average Remaining Contractual life in years | 4 years 2 months 23 days |
Exercise Price 0.0115 [Member] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.0115 |
Warrants Outstanding, Number Outstanding | 168,519,466 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 years 5 months 23 days |
Warrants Exercisable, Number Exercisable | 168,519,466 |
Warrants Exercisable, Weighted Average Remaining Contractual life in years | 4 years 5 months 23 days |
Exercise Price 0.0345 [Member] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.0345 |
Warrants Outstanding, Number Outstanding | 15,000,000 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 2 years 3 months 7 days |
Warrants Exercisable, Number Exercisable | 10,312,500 |
Warrants Exercisable, Weighted Average Remaining Contractual life in years | 2 years 3 months 7 days |
Exercise Price 0.15 [Member] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.15 |
Warrants Outstanding, Number Outstanding | 15,166,667 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 2 years 11 months 15 days |
Warrants Exercisable, Number Exercisable | 15,166,667 |
Warrants Exercisable, Weighted Average Remaining Contractual life in years | 2 years 11 months 15 days |
Exercise Price 0.1875 [Member] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.1875 |
Warrants Outstanding, Number Outstanding | 2,426,667 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 2 years 11 months 15 days |
Warrants Exercisable, Number Exercisable | 2,426,667 |
Warrants Exercisable, Weighted Average Remaining Contractual life in years | 2 years 11 months 15 days |
Stockholders_ Equity (Details_6
Stockholders’ Equity (Details) - Schedule of option activity - Stock Options [Member] - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Shares Underlying options, Outstanding at beginning (in Shares) | 46,316,666 | 30,516,666 |
Weighted average exercise price, Outstanding at beginning | $ 0.15 | $ 0.15 |
Shares Underlying options, Outstanding at ending (in Shares) | 46,316,666 | 46,316,666 |
Weighted average exercise price, Outstanding at ending | $ 0.15 | $ 0.15 |
Shares Underlying options, Granted (in Shares) | 15,800,000 | |
Exercise price per share, Granted | ||
Weighted average exercise price, Granted | $ 0.14 | |
Shares Underlying options, Forfeited/Cancelled (in Shares) | ||
Exercise price per share, Forfeited/Cancelled | ||
Weighted average exercise price, Forfeited/Cancelled | ||
Shares Underlying options, Exercised (in Shares) | ||
Exercise price per share, Exercised | ||
Weighted average exercise price, Exercised | ||
Minimum [Member] | ||
Exercise price per share, Outstanding at beginning | 0.15 | |
Exercise price per share, Outstanding at ending | 0.04 | 0.04 |
Exercise price per share, Granted | 0.04 | |
Maximum [Member] | ||
Exercise price per share, Outstanding at beginning | 0.4 | |
Exercise price per share, Outstanding at ending | $ 0.4 | 0.4 |
Exercise price per share, Granted | $ 0.15 |
Stockholders_ Equity (Details_7
Stockholders’ Equity (Details) - Schedule of options outstanding and exercisable | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Options Outstanding, Number Outstanding | 46,316,666 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 8 years 8 months 8 days |
Options Outstanding, Weighted Average Exercise Price | $ / shares | $ 0.15 |
Options Exercisable, Number Exercisable | 39,233,333 |
Options Exercisable ,Weighted Average Exercise Price | $ / shares | $ 0.15 |
Options Exercisable, Weighted Average Remaining Contractual life in years | 8 years 9 months |
Exercise Price 0.04 [Member] | |
Options Outstanding, Exercise Price | $ / shares | $ 0.04 |
Options Outstanding, Number Outstanding | 800,000 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 9 years 5 months 15 days |
Options Exercisable, Number Exercisable | 800,000 |
Options Exercisable, Weighted Average Remaining Contractual life in years | 9 years 5 months 15 days |
Exercise Price 0.15 [Member] | |
Options Outstanding, Exercise Price | $ / shares | $ 0.15 |
Options Outstanding, Number Outstanding | 45,208,333 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 8 years 8 months 8 days |
Options Exercisable, Number Exercisable | 38,125,000 |
Options Exercisable, Weighted Average Remaining Contractual life in years | 8 years 8 months 26 days |
Exercise Price 0.24 [Member] | |
Options Outstanding, Exercise Price | $ / shares | $ 0.24 |
Options Outstanding, Number Outstanding | 208,333 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 7 years 10 months 24 days |
Options Exercisable, Number Exercisable | 208,333 |
Options Exercisable, Weighted Average Remaining Contractual life in years | 7 years 10 months 24 days |
Exercise Price 0.40 [Member] | |
Options Outstanding, Exercise Price | $ / shares | $ 0.4 |
Options Outstanding, Number Outstanding | 100,000 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 5 years 9 months |
Options Exercisable, Number Exercisable | 100,000 |
Options Exercisable, Weighted Average Remaining Contractual life in years | 5 years 9 months |
Net Loss Per Share (Details) -
Net Loss Per Share (Details) - Schedule of dilutive shares - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Anti-dilutive shares | 496,241,594 | 79,508,625 |
Convertible debt [Member] | ||
Anti-dilutive shares | 248,812,128 | 11,687,855 |
Stock options [Member] | ||
Anti-dilutive shares | 46,316,666 | 30,516,666 |
Warrants to purchase shares of common stock [Member] | ||
Anti-dilutive shares | 201,112,800 | 37,304,104 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 13, 2022 | Jul. 11, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | |
James Fuller [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 200,000 | |||
Exercise price (in Dollars per share) | $ 0.04 | |||
Option expense | $ 0 | $ 7,993 | ||
William Corbett [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 15,000,000 | |||
Exercise price (in Dollars per share) | $ 0.15 | |||
Option expense | 66,587 | 1,090,201 | ||
Clifford Henry [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 200,000 | |||
Exercise price (in Dollars per share) | $ 0.04 | |||
Option expense | 0 | 7,993 | ||
Financial and capital markets advice | 3,500 | |||
Common stock, value | $ 7,993 | |||
Madisson Corbett [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 200,000 | |||
Exercise price (in Dollars per share) | $ 0.04 | |||
Option expense | 0 | 7,993 | ||
Common stock, value | $ 7,993 | |||
David Rios [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 200,000 | |||
Exercise price (in Dollars per share) | $ 0.04 | |||
Option expense | 0 | 7,993 | ||
Common stock, value | $ 7,993 | |||
Richard Rosenblum [Member] | ||||
Related Party Transactions (Textual) | ||||
Shares of common stock (in Shares) | 2,000,000 | |||
Option expense | $ 27,879 | $ 111,514 | ||
Common stock, value | $ 110,000 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | 1 Months Ended | ||
May 11, 2023 | Jun. 15, 2023 | May 10, 2023 | |
Subsequent Event [Member] | |||
Subsequent Events (Details) [Line Items] | |||
Aggregate principal amount | $ 117,320 | ||
Original issue discount | 12,570 | ||
Gross proceeds | $ 104,750 | ||
Interest charge | 13% | ||
Maturity date | May 10, 2024 | ||
Frictionless agreement description | the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless | ||
Forecast [Member] | |||
Subsequent Events (Details) [Line Items] | |||
Interest charge | 60% | ||
Repayments amount | $ 13,257.1 |